[EN] N-PHENYL-(HOMO)PIPERAZINYL-BENZENESULFONYL OR BENZENESULFONAMIDE COMPOUNDS SUITABLE FOR TREATING DISORDERS THAT RESPOND TO THE MODULATION OF THE 5-HT6 RECEPTOR [FR] COMPOSÉS DE TYPE N-PHÉNYL-(HOMO)PIPÉRAZINYL-BENZÈNESULFONYLE OU BENZÈNESULFONAMIDE APPROPRIÉS POUR LE TRAITEMENT DE TROUBLES QUI RÉPONDENT À LA MODULATION DU RÉCEPTEUR 5-HT6
[EN] N-PHENYL-(HOMO)PIPERAZINYL-BENZENESULFONYL OR BENZENESULFONAMIDE COMPOUNDS SUITABLE FOR TREATING DISORDERS THAT RESPOND TO THE MODULATION OF THE 5-HT6 RECEPTOR [FR] COMPOSÉS DE TYPE N-PHÉNYL-(HOMO)PIPÉRAZINYL-BENZÈNESULFONYLE OU BENZÈNESULFONAMIDE APPROPRIÉS POUR LE TRAITEMENT DE TROUBLES QUI RÉPONDENT À LA MODULATION DU RÉCEPTEUR 5-HT6
N-PHENYL-(HOMO)PIPERAZINYL-BENZENESULFONYL OR BENZENESULFONAMIDE COMPOUNDS SUITABLE FOR TREATING DISORDERS THAT RESPOND TO THE MODULATION OF THE SEROTONIN 5-HT6 RECEPTOR
申请人:Haupt Andreas
公开号:US20120142674A1
公开(公告)日:2012-06-07
The present invention relates to N-Phenyl-(homo)piperazinyl-benzenesulfonyl or benzenesulfonamide compounds of formula I
wherein the variables have the meanings given in the claims and the description, pharmaceutical compositions containing them, and their use in therapy. The compounds possess valuable therapeutic properties and are particularly suitable for treating diseases that respond to modulation of the serotonin 5-HT
6
receptor.
[EN] N-PHENYL-(HOMO)PIPERAZINYL-BENZENESULFONYL OR BENZENESULFONAMIDE COMPOUNDS SUITABLE FOR TREATING DISORDERS THAT RESPOND TO THE MODULATION OF THE 5-HT6 RECEPTOR<br/>[FR] COMPOSÉS DE TYPE N-PHÉNYL-(HOMO)PIPÉRAZINYL-BENZÈNESULFONYLE OU BENZÈNESULFONAMIDE APPROPRIÉS POUR LE TRAITEMENT DE TROUBLES QUI RÉPONDENT À LA MODULATION DU RÉCEPTEUR 5-HT6
申请人:ABBOTT GMBH & CO KG
公开号:WO2012059432A1
公开(公告)日:2012-05-10
The present invention relates to N-Phenyl-(homo)piperazinyl-benzenesulfonyl or benzenesulfonamide compounds of formula I wherein the variables have the meanings given in the claims and the description, pharmaceutical compositions containing them, and their use in therapy. The compounds possess valuable therapeutic properties and are particularly suitable for treating diseases that respond to modulation of the serotonin 5-HT6 receptor.